Next #TumorBoardTuesday 🧵 you may have missed

⏪ Rewind ⏪ to our fabulous fireside chat featuring a brief discussion on safety & management of #EndometrialCancer with @DrMMurphy @drteplinsky

Sit back & listen while grabbing a bite to eat.
#gyncsm
---
RT @TumorBoardTues
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu gra…
https://twitter.com/TumorBoardTues/status/1616239139082625024

EC Fireside Chat — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly when used in combinations in Endometrial Carcinoma (EC). Strategies to prevent, evaluate and manage co

Current Activities

8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

#CME🔗http://bit.ly/3hYxu3R

🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

Combine and Conquer: Minimizing the Impact of Toxicity Associated with Novel Immunotherapy-Angiogenesis Inhibitor Combinations Endometrial Carcinoma Fireside Chat *Post-Test*

Take this survey powered by surveymonkey.com. Create your own surveys for free.

7/#TumorBoardTuesday #GynCSM

🔴#PostTest Q3️⃣
📊Pt receiving pembro + lenva combo for past 12m
🗓@ f/u presented w persistently high levels of TSH
🟥Lenva withheld, but TSH levels remain high (>10mIU/L)

🔴What is the most appropriate next step in the mgmt of this pt?

6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
#CME 🔗http://bit.ly/3hYxu3R

🔴#PostTest Q 2️⃣
📊During tx w pembro + lenva, pt develops grd 3 diarrhea
🛑Lenva held
💊Loperamide Rx
Grade3️⃣diarrhea persists

🔴Which is the appropriate next step for this pt?

Combine and Conquer: Minimizing the Impact of Toxicity Associated with Novel Immunotherapy-Angiogenesis Inhibitor Combinations Endometrial Carcinoma Fireside Chat *Post-Test*

Take this survey powered by surveymonkey.com. Create your own surveys for free.

5/ Thanks #TumorBoardTuesday & #gyncsm!

🏆Claim #CME http://bit.ly/3hYxu3R
⬇️Answer #PostTest👇

🔴#PostTest Q1️⃣
📊Diarrhea, nausea, & vomiting are common GI tox associated w pembro + lenvatinib combo tx
🔴Which other tox may occur if these GI tox r not effectively managed?

Combine and Conquer: Minimizing the Impact of Toxicity Associated with Novel Immunotherapy-Angiogenesis Inhibitor Combinations Endometrial Carcinoma Fireside Chat *Post-Test*

Take this survey powered by surveymonkey.com. Create your own surveys for free.

Very nice RT @TumorBoardTuesday: 4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇

4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇

3/#TumorBoardTuesday #gyncsm #OncTwitter

🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?

Don't fret, it's here📍

---
RT @BonumCe
1/ #OncTwitter #TumorBoardTuesday
#EndometrialCancer #MedTweetorial🧵
w @DrMMurphy @MeganLeigh127 @TumorBoardTues

🧬Tx response
🧪Trial results
🔬Tox for TKI-ICI

🆓#CME 🔗 http://bit.ly/3VBGJEJ
Supported by educational grants from Eisai & @Merck
https://twitter.com/BonumCe/status/1615519240542646275

EC Tweetorial — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit

Current Activities

3/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

🟠Earn 🆓 #CME 🏆
🟠#CME ℹ️🔗http://bit.ly/3YRDkog

📸 Faculty disclosures & important CME info 👇

Combine and Conquer: Minimizing the Impact of Toxicity Associated with Novel Immunotherapy-Angiogenesis Inhibitor Combinations Endometrial Carcinoma Fireside Chat *Pre-Test*

Take this survey powered by surveymonkey.com. Create your own surveys for free.

💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ
EC Fireside Chat — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly when used in combinations in Endometrial Carcinoma (EC). Strategies to prevent, evaluate and manage co

Current Activities